Physician profile
Raymond F Lower
NPI 1083730485
$378.92
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $194.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $117.17 | 2019-2020 | |
| Bioventus LLC | $61.12 | 2019-2020 | |
| Depuy Synthes Sales INC. | $50.95 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $39.40 | 2019-2020 | |
| Innovation Technologies INC | $36.46 | 2020 | |
| Pacira Therapeutics, INC. | $31.05 | 2019 | |
| Integra Lifesciences Corporation | $20.04 | 2020 | |
| Ferring Pharmaceuticals INC. | $11.39 | 2019 | |
| Orthofix Medical, INC. | $11.34 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Lower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.